OGXI

  • Last Update

  • Change

  • Volume / Avg.

  • Prev. Close

Today's Performance

52-Week Range

OncoGenex Pharmaceuticals, Inc.

OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development & commercialization of therapies that address treatment resistance in cancer patients. It has three product candidates in pipeline: custirsen, apatorsen & OGX-225.